RT @CarlosdelRio7: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly @NEJM https://t.co/oEIgh43oXv A practice…
RT @CarlosdelRio7: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly @NEJM https://t.co/oEIgh43oXv A practice…
This is a big trial that should change our practice. https://t.co/NhR5oRm7pc
RT @CarlosdelRio7: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly @NEJM https://t.co/oEIgh43oXv A practice…
RT @CarlosdelRio7: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly @NEJM https://t.co/oEIgh43oXv A practice…
RT @CarlosdelRio7: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly @NEJM https://t.co/oEIgh43oXv A practice…
RT @CarlosdelRio7: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly @NEJM https://t.co/oEIgh43oXv A practice…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly @NEJM https://t.co/oEIgh43oXv A practice changing study showing the lack of benefit (and actual risk) of taking low dose aspirin for adults > 65.
...and to think, we've only had #RCT evidence in support of reversing the antiquated (and, from #nsgy perspective, potentially dangerous) ASA recommendation for 3 years! (via @NEJM https://t.co/Zj7K2p2sMb)
Aspirina, Buena o mala para la salud? https://t.co/W2hSgCUwOf El uso de aspirina en dosis bajas como estrategia de prevención primaria en adultos mayores resultó en un riesgo significativamente mayor de hemorragia mayor y no resultó en un riesgo significa
Que dice The New Egland Journal of Medicine sobre el uso frecuente de la aspirina para prevenir algunos problemas de salud? Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/Q6lx62yd4s
For secondary prevention, the evidence for ASA is compelling, w/⬆️characterized benefits (vs risks). But for primary prevention, conflicting evidence prevails for benefits: https://t.co/bSPCbZqdDR & prior work, eg https://t.co/WHx5fyeWmX Rx must
@fladdict 脳梗塞や心筋梗塞を起こしたことがない人の場合は、心筋梗塞や脳梗塞は減らず、脳出血などはちょっと増えるからですね。 https://t.co/CQruiGHPeU https://t.co/QdHKNkcFSc
No es lo mismo sucede con Aspirina y prevención “primaria”? https://t.co/Ww60BE1Sej
Why is " 'Elderly' defined as >70 for White and >65 for Black/Hispanic."? 🧵👇🏿#HealthEquity
Inpatient Lesson of the Day 7: I remember the findings from this 2018 @NEJM study that aspirin ⬆️ bleeding risk but didn't ⬇️ CVD risk in the elderly. What I didn't remember is that "elderly" was defined as >70 for White and >65 for Black/Hispanic.
RT @cardio_trials: Synopsis of trials evaluating Aspirin's use for primary prevention of cardiovascular disease. #cardiovascularmedicine #F…
Synopsis of trials evaluating Aspirin's use for primary prevention of cardiovascular disease. #cardiovascularmedicine #FOAM https://t.co/qcj3PsYVXg https://t.co/1ab2M86H2w https://t.co/tNRq3BdLPZ https://t.co/PG3EhXJl7b
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly アスピリンは脳出血は減少させるが、心血管イベントには有意差なし。NEJM https://t.co/o0MPRE4sdJ
@nsvcuralaba Hola, fue el ASPREE. Ojo que evaluó prevención primaria en adultos mayores sanos. Observaron que el riesgo de sangrados mayores superaba al beneficio de la reducción de eventos cardiovasculares. Nadie discute la prevención secundaria con aspi
Furthermore, it was found that those in the trial arm, prescribed aspirin, had a higher risk of experiencing major hemorrhagic events. The link to the study can be found here: https://t.co/gd7O0yJIaU.
@Boghuma @JAHA_AHA @vmarconi2 @EmoryCFAR Q from clinic-based on data for aspirin you show, and NEJM trial https://t.co/FDLuMhIXLg, do you not use ASA for primary prevention? Or do you still use since no clinical endpoint data in HIV? If you don't routinely
Aspirin does not protect healthy people against heart attacks https://t.co/Th9Q0Qmi4z
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/pFQ2l8WrZz
@interneurona Está bien depende del objetivo pero tbn de la población. En el estudio de @TheLancet 11% tenían enfermedad cardiovascular previa, criterio de exclusión en el estudio de @NEJM. Recuerda que Aspree demostró + sangrado >, sin beneficio en rie
Great thread
RT @AlishyaBurrell: Dug back in @camilla_wong’s feed for these gems from CGS 2019 in Halifax! For anyone three weeks away from their Geri @…
Dug back in @camilla_wong’s feed for these gems from CGS 2019 in Halifax! For anyone three weeks away from their Geri @Royal_College exam... may come in super handy! live tweeting this quickly isn’t easy - greatly appreciated! @CanGeriSoc @GeriInterestGp
RT @jvillacastin: Se debe recomendar la toma de aspirina 100 mg a personas sanas, mayores de 65-70 años? En este estudio, a los 5 años los…
RT @doctormacias: Si se compara con placebo, la aspirina como prevención en adultos mayores aumenta el riesgo de hemorragia y no reduce el…
This conclusion must be balanced with results of another study (https://t.co/sbSLTQGEYG)showing the dangers of low dose aspirin in healthy elderly.
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/axTkOqhHeW
RT @dr_raulmedina: En personas de más de 70 años sin enfermedad cardiovascular clínicamente manifiesta, la aspirina NO previene eventos car…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly https://t.co/ZUNYbcn86O https://t.co/0sCD3yjqWB
@HowellJollyBody Follow-up time & sample size would both need to be longer/larger. ECLAP had trouble recruiting per the NEJM 2004 paper that discussed the study findings. We also know that when ASA was studied prospectively re CV events results were un
El uso de dosis bajas de aspirina no protege de discapacidad ni previene eventos cardiovasculares, sino que aumenta el riesgo de presentar hemorragias en el adulto mayor según éste estudio: https://t.co/F2vtq1lRYh https://t.co/nOE2lpSpQD
@lilithstuff @sargesalute @Alisdisgrace (3/3) Regarding aspirin in primary prevention (separate from the NICE advice here), as @lilithstuff said, there was a good paper in the New England Journal of Medicine last year (found here: https://t.co/h7HAFr3Mai)
RT @neuropuc: @EBlackburnMD Así es! Estudio ASPREE 👇 https://t.co/lTcxo6qlBt
@EBlackburnMD Así es! Estudio ASPREE 👇 https://t.co/lTcxo6qlBt
And that’s all until next year, folks! @CanGeriSoc @NGIG1415 #CGSHalifax2019
#1. ASPREE (more than one publication): https://t.co/mVlSnfCBBf and https://t.co/Cu2Lx4Ay4n #CGSHALIFAX2019
RT @SciPubTas: Mark Nelson from @ResearchMenzies at #MarchForScience #Hobart talking about his amazing research on#asprin use in elderly fo…
Mark Nelson from @ResearchMenzies at #MarchForScience #Hobart talking about his amazing research on#asprin use in elderly folks. @UTAS_ https://t.co/T2e4tH0qNR https://t.co/ioS6tFcE0p
@AndrewMIbrahim This one has to be the biggest I can think of 🤯 https://t.co/Lfj2pIUcsr
.@American_Heart & @ACCinTouch now say not to take daily aspirin if you have no history of heart attack or stroke––a major study in the #NEJM shows that daily aspirin does nothing to prolong life and greatly increases the risk of gastrointestinal bleed
@cgwoodMD Since this is Twitter: https://t.co/1uqgE8R3r7
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @NEJM: ASPREE trial: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly https://t.co/XPjVR3gDh4 Editorial:…
RT @NEJM: #VisualAbstract: Using low-dose #aspirin as a primary prevention strategy in older adults results in a significantly higher risk…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/ajAMGFWw5S
Should healthy people take a daily aspirin? Recent clinical trail concluded that the risk of side effects from using aspirin for primary prevention of cardiovascular disease, particularly hemorrhage, outweighed the potential benefit. #biom4180 https://t.co
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly https://t.co/G5xkuLG7H8
Dosis bajas de aspirina como estrategia de prevención primaria en adultos mayores resultó en un riesgo significativamente mayor de hemorragia mayor y no dio como resultado un riesgo significativamente menor de enfermedad cardiovascular que el placebo. htt
RT @Borjaibanez1: @rmartinreyes @quironsalud @Hospital_LaLuz @Hospital_FJD @FdezLlamazares @JoseJuanatey @pablobusca Y solo en prevención s…
@rmartinreyes @quironsalud @Hospital_LaLuz @Hospital_FJD @FdezLlamazares @JoseJuanatey @pablobusca Y solo en prevención secundaria (no en quienes nunca han tenido un evento cardiovascular) https://t.co/uKks5V5AQM
In older persons without known cardiovascular disease, the use of low-dose aspirin resulted in a significantly higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease than placebo. #hearthealthmonth https:
RT @ahmed_ak97: This article suggests that the benefits of #aspirin as a preventive measure of #ischemic events does not outweigh the hemor…
RT @NEJM: #VisualAbstract: Using low-dose #aspirin as a primary prevention strategy in older adults results in a significantly higher risk…
@toni_waly @l_adhm @Anoo_6l "CONCLUSIONS The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease th
This article suggests that the benefits of #aspirin as a preventive measure of #ischemic events does not outweigh the hemorrhage risks. Unexpected result/interpretation, perhaps there is a confounder? #biom4180 https://t.co/2yfNqLwD5a
Effect of Aspirin on Cardiovascular health is not what we were fed. https://t.co/macionJBKE -via Flynx
Interesting
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. - PubMed - NCBI https://t.co/KV7F1Xfm5v
Y ahora, a complementar, comparar o “echar a pelear” con el trabajo reciente del @NEJM: https://t.co/po5r7YtdhO que parecía sepultar a la aspirina en prevención primaria. Otra cosa, vean los distintos twits asociados, todos opinan distinto sobre un mismo r
Effect of #Aspirin on #Cardiovascular Events and #Bleeding in the Healthy #Elderly | #NEJM https://t.co/fIQKi5ohye
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/VnaleDtwN4
RT @JJBG_07: The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major…
RT @JJBG_07: The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major…
RT @OK_biom4180: Interesting study finds that the use of low-dose aspirin as a preventative measure for cardiovascular events in healthy el…
The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease than placebo. https://t.co/dkhrXfaBUP
RT @angelopezh: El uso de la aspirina a dosis bajas en prevención primaria en adultos mayores, resultó en un riesgo significativamente mayo…
RT @HelenPHudson: Low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major hemorr…
Low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease than placebo. | NEJM https://t.co/1KRLjefj4J
RT @angelopezh: El uso de la aspirina a dosis bajas en prevención primaria en adultos mayores, resultó en un riesgo significativamente mayo…
RT @angelopezh: El uso de la aspirina a dosis bajas en prevención primaria en adultos mayores, resultó en un riesgo significativamente mayo…
RT @angelopezh: El uso de la aspirina a dosis bajas en prevención primaria en adultos mayores, resultó en un riesgo significativamente mayo…